Information Technology Reference
In-Depth Information
37. Schlosstein L et al (1973) High association of an HL-A antigen, W27, with ankylosing
spondylitis. N Engl J Med 288(14):704 - 706
38. Khan MA (1997) A worldwide overview: the epidemiology of HLA-B27 and associated
spondyloarthritides. In: Calin A, Taurog J (eds) Spondyloarthritides. Oxford University Press,
New York, pp 17 - 26
39. van der Linden SM et al (1984) The risk of developing ankylosing spondylitis in HLA-B27
positive individuals. A comparison of relatives of spondylitis patients with the general
population. Arthritis Rheum 27(3):241
249
40. Spondyloarthritis Australo-Anglo-American (2010) C., et al., Genome-wide association study
of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42(2):123
-
127
41. Evans DM et al (2011) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis
implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat
Genet 43(8):761
-
767
42. International Genetics of Ankylosing Spondylitis Consortium (2013) Identi cation of multiple
risk variants for ankylosing spondylitis through high-density genotyping of immune-related
loci. Nat Genet 45(7):730 - 738
43. Taurog JD et al (1994) The germfree state prevents development of gut and joint inflammatory
disease in HLA-B27 transgenic rats. J Exp Med 180(6):2359 - 2364
44. Braun J et al (1995) Use of immunohistologic and in situ hybridization techniques in the
examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.
Arthritis Rheum 38(4):499 - 505
45. McGonagle D et al
-
(2002) Histological assessment of
the early enthesitis lesion in
537
46. Lories RJ, Schett G (2012) Pathophysiology of new bone formation and ankylosis in
spondyloarthritis. Rheum Dis Clin North Am 38(3):555
spondyloarthropathy. Ann Rheum Dis 61(6):534
-
567
47. Brown MA et al (1997) Susceptibility to ankylosing spondylitis in twins: the role of genes,
HLA, and the environment. Arthritis Rheum 40(10):1823
-
1828
48. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for
ankylosing spondylitis. A proposal for modi cation of the New York criteria. Arthritis Rheum
27(4):361
-
368
49. Braun J, Baraliakos X (2011) Imaging of axial spondyloarthritis including ankylosing
spondylitis. Ann Rheum Dis 70(Suppl 1):i97-i103
-
1):i97-i103
50. Maksymowych WP et al (2013) Suppression of in
-
ammation and effects on new bone
formation in ankylosing spondylitis: evidence for a window of opportunity in disease
modi cation. Ann Rheum Dis 72(1):23 - 28
51. Tan S et al (2013) Quantitative syndesmophyte measurement in ankylosing spondylitis using
CT: longitudinal validity and sensitivity to change over 2 years. Ann Rheum Dis
52. Gladman DD et al (1987) Psoriatic arthritis (PSA) an analysis of 220 patients. Q J Med 62
(238):127 - 141
53. Gladman DD et al (2011) Do patients with psoriatic arthritis who present early fare better than
those presenting later in the disease? Ann Rheum Dis 70(12):2152
fl
2154
54. Madland TM et al (2005) Prevalence, disease manifestations, and treatment of psoriatic
arthritis in Western Norway. J Rheumatol 32(10):1918
-
1922
55. Moll JM, Wright V (1973) Familial occurrence of psoriatic arthritis. Ann Rheum Dis 32
(3):181
-
201
56. Kane D et al (2003) A prospective, clinical and radiological study of early psoriatic arthritis:
an early synovitis clinic experience. Rheumatology (Oxford) 42(12):1460
-
1468
57. Gladman DD, Farewell VT, Nadeau C (1995) Clinical indicators of progression in psoriatic
arthritis: multivariate relative risk model. J Rheumatol 22(4):675
-
679
-
58. Kaltwasser JP et al (2004) Ef cacy and safety of le
unomide in the treatment of psoriatic
arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical
trial. Arthritis Rheum 50(6):1939 - 1950
fl
Search WWH ::




Custom Search